Zydus Wellness Limited (NSE:ZYDUSWELL) released its unaudited consolidated financial results for the quarter ended June 30, 2026 on August 4, 2026, reporting net sales of Rs 14,299 million, a year-on-year increase of 66.7% compared to Rs 8,577 million in Q1 FY26.
Key Highlights
- Consolidated net sales rose 66.7% year-on-year to Rs 14,299 million in Q1 FY27, against Rs 8,577 million in the corresponding quarter of the previous year.
- EBITDA for Q1 FY27 stood at Rs 2,417 million, reflecting a growth of 55.3% over the year-ago period, as disclosed in the press release.
- Net profit for the quarter was reported at Rs 1,189 million on a consolidated basis for the period ended June 30, 2026.
- Sugar Free retained a 96.1% market share in the sugar substitute category and Glucon-D held a 59.1% market share, both as per MAT June 2026 Nielsen and IQVIA data.
About the Company
Zydus Wellness Limited (NSE:ZYDUSWELL), headquartered in Ahmedabad, is a consumer health and wellness company in the FMCG and consumer brands sector. Its portfolio spans sugar substitutes under the Sugar Free brand, glucose-based nutrition drinks under Glucon-D, the Everyuth skincare range, Nycil prickly heat powder, protein nutrition under RiteBite Max Protein, Complan nutritional beverages, and Nutralite fat spreads, marketed across India and international markets.
Announcement in Detail
The press release submitted to both BSE and NSE on August 4, 2026 by Company Secretary Nandish P. Joshi covers unaudited consolidated results for Q1 FY27. Net sales of Rs 14,299 million compare with Rs 8,577 million a year ago, while EBITDA of Rs 2,417 million and net profit of Rs 1,189 million were reported for the same period.
On the brand side, Sugar Free's core offerings Sugar Free D'Lite and I'm Lite delivered double-digit growth. The company launched VieMax Diabetes Care, a nutrition product targeting blood sugar management via a low glycaemic index, high-protein, high-fibre formulation. Complan entered the ready-to-drink segment with Complan Power Play milk shake in vanilla and chocolate flavours, carrying no added sugar or preservatives. Under the Comfort Click portfolio, WeightWorld expanded into the Walmart Marketplace in the USA, and both WeightWorld and Maxmedix were launched on the Noon e-commerce platform in the UAE.
Impact on Investors
The filing shows a meaningful gap between top-line growth of 66.7% and EBITDA growth of 55.3%, indicating that operating costs expanded at a faster rate than revenue in Q1 FY27. Investors will note that the EBITDA margin implied by the disclosed figures narrowed relative to the revenue growth rate, which is a factor the disclosed terms indicate warrants monitoring in subsequent quarters.
Shareholders will observe that new product launches, including VieMax Diabetes Care and Complan Power Play, represent early-stage revenue streams whose contribution to consolidated financials has not been separately quantified in the announcement. The international DTC expansion into the Walmart Marketplace and Noon platforms adds geographic diversification, though scale and contribution from these channels are not disclosed in the filing.
Sector / Market Context
India's FMCG sector has seen sustained premiumisation and a shift toward health and functional nutrition products, a trend documented by industry bodies including FICCI and FMCG majors in their annual disclosures. The sugar substitute, protein nutrition, and specialised dietary management categories have attracted increasing consumer attention as lifestyle-related health concerns, including diabetes and obesity, gain prominence in urban and semi-urban markets. The ready-to-drink nutrition beverage format is an expanding sub-segment within this broader category, with multiple established and new entrants competing for shelf and digital space.